Jubilant Life Sciences Ltd (JULS.NS)
JULS.NS on National Stock Exchange of India
820.60INR
18 May 2018
820.60INR
18 May 2018
Change (% chg)
Rs9.75 (+1.20%)
Rs9.75 (+1.20%)
Prev Close
Rs810.85
Rs810.85
Open
Rs810.85
Rs810.85
Day's High
Rs835.75
Rs835.75
Day's Low
Rs810.85
Rs810.85
Volume
531,971
531,971
Avg. Vol
1,021,517
1,021,517
52-wk High
Rs1,039.00
Rs1,039.00
52-wk Low
Rs600.00
Rs600.00
Consensus Recommendations
| Consensus Recommendation | Next Earnings (approx.) | Company Fiscal Year End Month |
Last Updated |
|---|---|---|---|
| Outperform | 12.55 | March | 21 May 2018 |
Analyst Recommendations and Revisions
| 1-5 Linear Scale | Current | 1 Month Ago |
2 Month Ago |
3 Month Ago |
|---|---|---|---|---|
| (1) BUY | 5 | 4 | 4 | 4 |
| (2) OUTPERFORM | 8 | 8 | 8 | 8 |
| (3) HOLD | 0 | 0 | 0 | 0 |
| (4) UNDERPERFORM | 0 | 1 | 1 | 1 |
| (5) SELL | 0 | 0 | 0 | 0 |
| No Opinion | 0 | 0 | 0 | 0 |
| Mean Rating | 1.62 | 1.85 | 1.85 | 1.85 |
Consensus Estimates Analysis
Sales and Profit Figures in India Rupee (INR)
Earnings and Dividend Figures in India Rupee (INR)
Earnings and Dividend Figures in India Rupee (INR)
| # of Estimates | Mean | High | Low | 1 Year Ago |
|
|---|---|---|---|---|---|
| SALES (in millions) | |||||
| Quarter Ending Mar-18 | 6 | 20,792.20 | 22,074.00 | 19,716.00 | -- |
| Year Ending Mar-18 | 13 | 73,457.80 | 75,533.00 | 71,879.00 | -- |
| Year Ending Mar-19 | 13 | 89,971.90 | 93,790.00 | 85,809.00 | 73,327.90 |
| Year Ending Mar-20 | 13 | 100,536.00 | 106,570.00 | 95,135.40 | -- |
| Earnings (per share) | |||||
| Quarter Ending Mar-18 | 2 | 12.55 | 13.90 | 11.20 | -- |
| Year Ending Mar-18 | 13 | 44.74 | 53.40 | 36.97 | -- |
| Year Ending Mar-19 | 13 | 60.40 | 65.40 | 55.48 | 62.47 |
| Year Ending Mar-20 | 13 | 74.20 | 81.90 | 65.26 | -- |
Historical Surprises
Sales and Profit Figures in India Rupee (INR)
Earnings and Dividend Figures in India Rupee (INR)
Earnings and Dividend Figures in India Rupee (INR)
| Estimates vs Actual | Estimate | Actual | Difference | Surprise % |
|---|---|---|---|---|
| SALES (in millions) | ||||
| Quarter Ending Mar-18 | 20,792.20 | 22,237.70 | 1,445.53 | 6.95 |
| Quarter Ending Dec-17 | 18,223.40 | 20,414.70 | 2,191.29 | 12.02 |
| Quarter Ending Sep-17 | 16,724.70 | 16,211.60 | 513.13 | 3.07 |
| Quarter Ending Jun-17 | 16,233.00 | 15,383.80 | 849.20 | 5.23 |
| Quarter Ending Mar-17 | 15,878.60 | 15,657.90 | 220.67 | 1.39 |
| Earnings (per share) | ||||
| Quarter Ending Mar-18 | 12.55 | 9.94 | 2.61 | 20.80 |
| Quarter Ending Dec-17 | 8.51 | 13.64 | 5.13 | 60.28 |
| Quarter Ending Sep-17 | 10.09 | 8.23 | 1.86 | 18.43 |
| Quarter Ending Jun-17 | 12.40 | 9.44 | 2.96 | 23.87 |
| Quarter Ending Mar-17 | 11.10 | 9.63 | 1.47 | 13.24 |
Consensus Estimates Trend
Sales and Profit Figures in India Rupee (INR)
Earnings and Dividend Figures in India Rupee (INR)
Earnings and Dividend Figures in India Rupee (INR)
| Current | 1 Week Ago |
1 Month Ago |
2 Month Ago |
1 Year Ago |
|
|---|---|---|---|---|---|
| SALES (in millions) | |||||
| Quarter Ending Mar-18 | 20,792.20 | -- | -- | -- | -- |
| Year Ending Mar-18 | 73,457.80 | -- | -- | -- | -- |
| Year Ending Mar-19 | 89,971.90 | 89,021.70 | 87,604.10 | 87,604.10 | 73,327.90 |
| Year Ending Mar-20 | 100,536.00 | 99,892.00 | 98,303.10 | 98,303.10 | -- |
| Earnings (per share) | |||||
| Quarter Ending Mar-18 | 12.55 | -- | -- | -- | -- |
| Year Ending Mar-18 | 44.74 | -- | -- | -- | -- |
| Year Ending Mar-19 | 60.40 | 61.26 | 60.10 | 60.10 | 62.47 |
| Year Ending Mar-20 | 74.20 | 74.72 | 73.93 | 73.93 | -- |
Estimates Revisions Summary
| Last Week | Last 4 Weeks | |||
|---|---|---|---|---|
| Number Of Revisions: | Up | Down | Up | Down |
| Revenue | ||||
| Quarter Ending Mar-18 | -- | -- | -- | -- |
| Year Ending Mar-18 | -- | -- | -- | -- |
| Year Ending Mar-19 | 5 | 0 | 12 | 0 |
| Year Ending Mar-20 | 4 | 0 | 9 | 1 |
| Earnings | ||||
| Quarter Ending Mar-18 | -- | -- | -- | -- |
| Year Ending Mar-18 | -- | -- | -- | -- |
| Year Ending Mar-19 | 1 | 4 | 7 | 5 |
| Year Ending Mar-20 | 1 | 3 | 5 | 4 |
Earnings vs. 
Estimates- BRIEF-Jubilant Life Sciences, Jubilant Stock Holding, Others File Appeals Against SEBI Adjudication Order
- BRIEF-Jubilant Life Sciences Issues Commercial Papers Worth 750 Mln Rupees
- BRIEF-Jubilant Life Sciences Says Home Dept Stays Order Cancelling Licenses For Co's Distillery Operations At Nira
- BRIEF-Jubilant Life Sciences Says Unit Got ANDA Approval For Amantadine Hydrochloride Tablets
- BRIEF-Jubilant Life Sciences Says Unit Got ANDA Approval For Clonidine Hydrochloride Extended-Release Tablets